SYK and lung carcinoma: Consistently, in the in vivo xenograft model, compared to control mice, mice bearing MET-amplified EBC-1 lung cancer cells with stable SYK knockdown exhibited a significantly reduced response to the c-Met inhibitor INCB28060 (Fig. 1h).